Assignee
ULTIMOVACS AS
NO·5 granted patents·4 citations·filing 2017–2022
Top patents by PatentIndex Score
5 records- 0183US10383928B2Telomerase polypeptide vaccine for treating cancerULTIMOVACS AS·Filed 2017·Granted Aug 20, 2019·4 cites·30 claims
- 0275US11998595B2Telomerase polypeptide vaccine for treating cancerULTIMOVACS AS·Filed 2019·Granted Jun 4, 2024·0 cites·15 claims
- 0370US12168045B2Vaccine in combination with an immune checkpoint inhibitor for use in treating cancerULTIMOVACS AS·Filed 2022·Granted Dec 17, 2024·0 cites·32 claims
- 0465US11529403B2Telomerase polypeptide vaccine for treating cancerULTIMOVACS AS·Filed 2017·Granted Dec 20, 2022·0 cites·20 claims
- 0561US11419927B2Vaccine in combination with an immune checkpoint inhibitor for use in treating cancerULTIMOVACS AS·Filed 2017·Granted Aug 23, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when ULTIMOVACS AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →